• 

  ‘Some Hope Over No Hope:’ A Retired Doctor on Alzheimer’s Diagnosis and the Aduhelm Trial
• 

  New Alzheimer’s Prediction Smartphone App Gets FDA Breakthrough Status
• 

  Alzheimer’s Disease: Five Common Myths to Dispel
• 

  Seeking Physical Exercise’s Brain Health Benefits in Saunas and Hot Tubs
• 

  Bio-Hermes Study Underway To Develop Cost-Effective Alzheimer’s Diagnostics
• 

  To Be Truly Dementia-Friendly, Communities Must Be Dementia-Inclusive
• 

  COVID-19 May Hasten Alzheimer’s Symptoms
• 

  Transgender and Nonbinary Adults More Likely to Develop Alzheimer’s Symptoms
• 

  Meet Lilly’s Investigational Alzheimer’s Drug Donanemab: A Q&A With Dr. David Weidman
• 

  Neuroscientist Daniela Kaufer: Aging, Disease, and the Blood-Brain Barrier
• 

  Some Hospitals Refuse to Offer Alzheimer’s Drug Aduhelm
• 

  The Jalisco Gene: A Military Pilot’s Story
• 

  Amyloid Hypothesis Twist: Restoring ‘Good’ Beta-Amyloid to Treat Alzheimer’s
• 

  Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow
• 

  FDA Limits the Use of Aduhelm After Criticisms of Broad Approval

Previous202122Next